Using vaccinia virus as a selection and cloning vehicle, a thymidine kinase (TK) gene of fowlpox virus (FPV) has been identified. A plasmid, pF130, containing part of the HindlII-F region of vaccinia virus was used to shotgun clone EcoRI fragments of FPV DNA into TK-vaccinia virus and select for TK ÷ recombinants. The TK ÷ recombinant vaccinia virus contained a 5.5 kb EcoRI fragment of FPV. This FPV fragment was cloned into pUC9 and the presence of the TK gene in this fragment was confirmed by its ability to rescue TK ÷ vaccinia virus from TK-virus, when inserted into pF130. A recombinant vaccinia virus containing this FPV fragment induced TK enzyme activity in the cytoplasm of infected cells. The vaccinia virus RNA polymerase appeared able to recognize the FPV promoter sequences of the FPV TK gene since the fragment operated in the marker rescue, irrespective of its orientation to the vaccinia virus promoter in pF130. Using restriction enzyme analysis, insertion of subfragments of the 5.5 kb FPV fragment into pF130 and marker rescue, we were able to map the position of the TK gene in the 5-5 kb EcoRI fragment. This approach may facilitate identification and cloning of TK genes from other poxviruses.
INTRODUCTION
Vaccinia virus is the most studied member of the orthopoxvirus group. Other members of this poxvirus group have been studied to a limited extent, while members of the other poxvirus groups have been largely neglected. Mapping and nucleotide sequence determination of the thymidine kinase (TK) gene of vaccinia virus (Hruby & Ball, 1982; Weir et al., 1982; Bajszar et al., 1983; Dubbs et al., 1983; Hruby et al., 1983; led to the development of a general method for the insertion of foreign DNA into vaccinia virus (Mackett et al., 1982 (Mackett et al., , 1984 . Alternative methods involved the identification of other non-essential regions of the vaccinia virus genome allowing non-selective Panicali et al., 1983; Paoletti et al., 1984) or selective (Mackett et al., 1982; insertion of foreign DNA. A variety of foreign genes have been inserted into and expressed by recombinant vaccinia virus, e.g. the TK (Mackett et al., 1982; and glycoprotein D genes of herpes simplex virus (HSV) (Paoletti et al., 1984) , the haemagglutinin gene of influenza virus (Panicali et al., 1983; Smith et al., 1983 b; Boyle et al., 1985) , the surface antigen of hepatitis B virus (Smith et al., 1983a; Paoletti et al., 1984) , the sporozoite antigen of malaria and genes from vesicular stomatitis (Mackett et al., 1985) and rabies viruses Wiktor et al., 1984) . Such recombinant vaccinia viruses have the potential to deliver vaccine antigens to a wide variety of species; however, the risk of spread back to man and the potential for disease problems from the widespread use of vaccinia virus in animals makes it desirable to construct recombinant poxviruses based on host-specific poxviruses, e.g. fowlpox virus (FPV) for poultry vaccines or orf virus for sheep vaccines. To achieve this requires considerable understanding of the molecular biology of these viruses, including the identification of nonessential regions into which foreign DNA might be inserted.
We have identified and cloned the TK gene of FPV with a view to developing techniques for the insertion and expression of foreign DNA in FPV. Recombinant avian poxviruses have great potential to deliver poultry and other avian vaccine antigens. In this study we used vaccinia virus as a selection and cloning vehicle to identify and characterize a FPV genome fragment containing a TK gene. The results indicate that vaccinia virus can be used to identify and clone genes of other poxviruses and possibly other DNA viruses. Vaccinia virus has already been used as a cloning vehicle to identify vaccinia virus genes determining the host range phenotype (Gil!ard et al., 1985) .
METHODS
Enzymes. Restriction endonucleases and DNA-modifying enzymes were obtained from several commercial suppliers and used according to the manufacturers' instructions or those described in detail by Maniatis et al. (1982) .
Viruses. An L929 cell-adapted vaccinia virus WR strain (VV-WR-L929) maintained in this laboratory was twice plaque-purified on human 143B TK-cells. A TK-vaccinia virus WR strain was generously provided by Dr B. Moss, NIH, Bethesda, Md., U.S.A. Fowlpox virus (Mild Vaccine strain; Arthur Webster Pty Ltd, Northmead, N SW 2152, Australia) was pock-purified twice on the chorioallantoic membrane of embryonated eggs. FPV was purified from the chorioallantoic membranes of infected eggs (Joklik, 1962) and the DNA extracted as described by Nakano et al. (1982) . Vaccinia virus-WR-L929 was purified from human 143B cell cultures and the DNA similarly extracted.
Cell line. Human 143B cells, a TK-variant of cell line R970-5 (Rhim et al., 1975) , were obtained from Dr K. Huebner (Wistar Institute, Philadelphia, Pa., U.S.A.) and grown in Eagle's basal medium with 5~ foetal bovine serum and 25 ~tg/ml of 5-bromodeoxyuridine (BUdR). Cells were passaged at least twice in the absence of BUdR prior to use in experiments.
Marker rescue. Marker rescue was performed essentially as described by Weir et al. (1982) . Cells were infected with TK-vaccinia virus strain WR at a multiplicity of 0.01 to 0.05 p.f.u./cell. At 2 h after infection, 1 p.g of calcium phosphate-precipitated plasmid DNA (with 20 ~tg calf thymus DNA as carrier) was added. Uncleaved recombinant plasmid DNA, prepared by the rapid alkaline lysis method, was used without further purification (Birnboim & Doly, 1979) . After a further 6 h the medium was changed to one containing 3 ktM-methotrexate, 15 ~tM-thymidine, 50 laM-adenosine, 50 ~tM-guanosine and 10 ~tM-glycine (MTAGG) to select for TK ÷ virus. Cells were harvested 48 h later. Virus plaque assays and differential assays for TK ÷ (MTAGG) and TK-(25 ~g/ml BUdR) viruses were performed on monolayers of human 143B cells (Weir et al., 1982) . Vaccinia virus recombinants (TK ÷) were isolated by plaquing in the presence of MTAGG and identified as having FPV DNA inserts by dot blot DNA:DNA hybridization (Mackett et al., 1982 (Mackett et al., , 1984 . Recombinant viruses were plaque-purified three times and amplified under MTAGG in TK-cell monolayers. Stock viruses were grown in 143B ceils.
Plasmids. pUC8 and pUC9 were obtained from Bethesda Research Laboratories (Vieira & Messing, 1982) . pF130 is a plasmid containing a 2.6 kb PstI-HinclI fragment from the HindlII-F fragment of VV-WR inserted into pUC8. All of the unique restriction enzyme sites of the original pUC8 multiple cloning site have been deleted and a multiple cloning site (HindllI, PstI, SalI/HinclI, BamHI, SmaI and EcoRI) has been inserted at the BamHI site next to the vaccinia virus promoter P-F in this fragment (Panicali et al., 1983; Boyle et al., 1985) . This plasmid, pF130, allows insertion of foreign DNA into a non-essential region of the HindlII-F fragment of the vaccinia virus genome. Details of the construction and characterization of pF 130 will be described elsewhere (B. E. H. Coupar & D. B. Boyle, unpublished) .
Preparation of cell lysatesfor TK assays. Extracts from infected cells were prepared essentially as described by Hruby & Ball (1981) . Confluent monolayers of 143B (TK-) cells were infected with 20 p.f.u./cell of virus or mockinfected. At appropriate times after infection, cells were harvested, washed twice with ice-cold phosphatebuffered saline containing I mM-MgCI2, then lysed on ice in 150 ~tl of extraction buffer (0.5 ~o Nonidet P40, 20 mM-HEPES pH 7.6, 2 raM-magnesium acetate, 1 mM-dithiothreitol and 50 rtM-thymidine) per 4 x 106 cells. Lysates were cleared by centrifugation and supernatants stored at -70 °C. Where indicated, cells were preincubated with 40 I~g/ml of cytosine arabinoside (Ara-C) for 15 min before infection with virus. Ara-C was included in the incubation medium at the same concentration.
TK assays. Enzyme assays were carried out essentially as described for HSV TK (Jamieson & Subak-Sharpe, 1974) . The assay mixture contained 10 ~M-[3H]thymidine (10 laCi/ml), 10 mM-ATP, 10 mM-MgC12, 20 mMphosphate buffer pH 6.0 and 25 ~tl cell extract in a total volume of 50 ~tl. Reaction mixtures were incubated at 37 °C for 15 min and the reactions stopped by boiling followed by cooling on ice. Phosphorylated thymidine was separated from unphosphorylated nucleoside by spotting 10 ~tl aliquots in triplicate from the assay supernatant onto Whatman DE81 paper discs. Discs were washed for 10 min at 37 °C in 4 mM-ammonium formate/10 I-tMthymidine, for 10 min at 37 °C in 4 mM-ammonium formate, for 5 min at room temperature in distilled water, rinsed in absolute alcohol, dried and counted in toluene/PPO scintillation fluid. Doubling dilutions of cell lysates were assayed to ensure that a linear relationship between sample volume and phosphorylated thymidine was maintained over the range used for quantification.
RESULTS

Cloning of FPV TK gene into vaccinia virus
Purified FPV DNA (1 gg/reaction) was digested with a minimal amount of EcoRI, just sufficient for complete digestion in 1 h. Separate samples of FPV DNA were digested using onehalf and one-quarter the quantity of EcoRI to give partial digests, pF130 (400 ng) was digested with EcoRI and treated with calf intestinal alkaline phosphatase (CIAP). The digested FPV DNA was pooled with the pF130 (EcoRI-digested and ClAP-treated), ethanol-precipitated and ligated with T4 DNA ligase for 1 h at 16 °C, then overnight at 4 °C. This ligated DNA mixture was used in the marker rescue experiments with TK-vaccinia virus WR. Differential assay of virus from this marker rescue yielded 3 x 102 p.f.u, ofTK + virus per culture (Table 1) . This virus stock was amplified once on TK-cells under MTAGG and the proportion of TK ÷ virus increased markedly. In control experiments (Table 2) we consistently failed to obtain TK-to TK ÷ revertants.
Twenty-four TK + plaques were picked from the original and amplified marker rescue virus stocks. When probed with 32p-labelled FPV DNA by blot hybridization, all 24 plaques hybridized. Under the stringency conditions used (0-1 x SSC, 0.I~ SDS, 42°C) FPV DNA failed to cross-hybridize with vaccinia virus DNA (data not shown). Four independent plaques from the original stock were plaque-purified three times under TK+-selective conditions (MTAGG). At the final plaque purification all plaques that grew on amplification hybridized with 32p_Fp V DNA. Stocks prepared from two of these plaque-purified viruses (VV-FPV-TK A and B) contained no detectable TK-virus (Table 1) . Only VV-FPV-TK A was used for further studies. 
Characterization of FP V DNA fragment in recombinant VV-FP V-TK
D N A was purified from VV-FPV-TK and analysed by restriction enzyme digestion and hybridization with 32p-labelled FPV D N A (Fig. l a) . Purified VV-WR-L929 D N A was analysed as a control. In the HindIII digest of VV-FPV-TK, the VV-WR-L929 HindIII-F fragment (13-6 kb) was replaced by 8.6 kb, 4.8 kb, 3.5 kb and several small fragments of 300 to 600 bp. The EcoRI fragment from FPV in VV-FPV-TK was further characterized by restriction enzyme digestion of FPV DNA and hybridization with 32p-VV-FPV-TK DNA (Fig. 2a) . VV-FPV-TK DNA hybridized with a single EcoRI fragment (5.5 kb), two PstI fragments (23 kb and 13 kb), two BamHI fragments (20 kb and 3.9 kb), a large unresolved SalI fragment, and several HindlII fragments (3.5 kb, 4-0 kb and small fragments of 300 to 600 bp).
Cloning of FPV-TK EcoRI fragment into pUC9 and mapping of TK gene
FPV DNA digested with EcoRI was cloned in pUC9. Two of 300 colonies screened hybridized with 32p-VV-FPV-TK DNA. Both plasmids (pDB1) contained the same 5.5 kb fragment of FPV DNA. Restriction enzyme analysis showed it to have a map similar to that of the FPV DNA fragment in VV-FPV-TK (Fig. 3) . Hybridization of 32p-pDBI to VV-FPV-TK DNA (Fig. I c) and FPV DNA (Fig. 2c) restriction enzyme digests showed that it hybridized to the same fragments as when 32p-FPV DNA hybridized to VV-FPV-TK DNA (Fig. 1 a) and as when 32p-VV-FPV-TK DNA hybridized to FPV DNA (Fig. 2a) .
To show that this FPV fragment contained the TK gene, it was inserted into pF130 at the EcoRI site in both orientations (pDB2 and pDB3, Fig. 4) . The 3-5 kb HindIII subfragment of the 5.5 kb EcoRI fragment was similarly inserted into pF130 at the HindlII site of the multiple cloning site (pDB4 and pDB5, Fig. 4 ). Both the EcoRI fragment and the HindlII fragment inserted into pF 130 were able to operate in the marker rescue, generating TK + virus from TK-( Table 2 ). They operated irrespective of the orientation of the FPV DNA fragment relative to the vaccinia virus promoter (P-F) in pF130. The 5-5 kb EcoRI fragment failed to operate in the marker rescue if it was not flanked by vaccinia virus sequences (pDB1, Table 2 ). This showed that the FPV DNA fragment was not undergoing recombination with the TK gene region of the TK-vaccinia virus to generate TK + virus.
XbaI or ClaI digestion of pDB4 or pDB5 and re-ligation was used to generate plasmids, pDB6 to pDB 11, which had a variety of deletions of fragments from the HindIII 3.5 kb FPV fragment contained in pFl30 (Fig. 4) . Those plasmids (pDB5, pDB9, pDB10 and pDBll) which contained a 2.2 kb HindIII-ClaI FPV fragment (which contained a 700 bp XbaI fragment) were still able to generate TK + virus from TK-virus in the marker rescue (Table 2, Fig. 4) . Plasmids (pDB6, pDB7, pDB8) from which the 700 bp XbaI FPV fragment had been deleted failed to generate TK + virus from TK-virus in the marker rescue (Table 2, Fig. 4) . This was so, irrespective of the orientation of the FPV fragment to the vaccinia virus promoter (P-F).
To confirm that TK + virus generated by marker rescue with plasmids pDB2, pDB4, pDBI0 and pDB11 contained FPV DNA, TK + plaques were picked and probed with 32p-pDB1. All TK + plaques hybridized with pDBI (data not shown). From these data the TK gene of FPV includes the region of the 700 bp XbaI fragment mapping to the left half of the 5.5 kb EcoRI fragment originally cloned into vaccinia virus (Fig. 3) .
TK assays on cells infected with recombinant virus VV-FPV-TK
TK activity in cells infected with wild-type VV-WR-L929 and recombinant VV-FPV-TK increased from 2 to 4 h after infection and reached maximal levels at 6 to 8 h. Mock-infected and VV-WR-TK--infected cells had no increase in TK activity over this period. At the same multiplicity of infection TK activity in VV-FPV-TK-infected cells reached 70% to 90% of the activity in VV-WR-L929-infected cells. Ara-C failed to inhibit the induction of TK activity by VV-FPV-TK virus, showing that the FPV TK promoter was operating as an early promoter in the vaccinia virus recombinant (Table 3) .
DISCUSSION
The large DNA genomes of the orthopoxviruses (Hruby & Ball, 1982; Weir et al., 1982; Bajszar et al., 1983; Dubbs et al., 1983; Hruby et al., 1983; Esposito & Knight, 1984) and the herpesviruses Otsuka & Kit, 1984; Wagner et al., 1981) have been shown to encode a viral TK gene. It was expected that FPV would have a viral TK gene since the FPV genome is very large, 260 to 270 kb (Mfiller et al., 1978) (approximately 1.5 times the size of the vaccinia virus genome of 180 kb). The use of vaccinia virus as a selection and cloning vehicle for the identification of the FPV TK gene proved to be a very powerful technique. The very low reversion frequency of TKvaccinia virus to TK + allowed the marker rescue of TK-to TK ÷ vaccinia virus to be used as a shotgun cloning protocol for the insertion of a FPV DNA fragment containing a TK gene into vaccinia virus. Previously the HSV TK gene had been inserted into vaccinia virus at this site; however, vaccinia virus regulatory promoter sequences were required for the expression of HSV TK activity .
Using this approach, a 5.5 kb EcoRI fragment of FPV was inserted into vaccinia virus. This fragment contained a functional TK gene on the basis of two criteria. First, it was able to rescue TK + vaccinia virus from TK-virus when inserted into pF130 and recombined into the vaccinia virus genome, and second the recombinant virus expressed TK enzyme activity in the cytoplasm of infected cells. By using the TK selection protocol and marker rescue, the functional TK gene was further mapped within the 5.5 kb EcoRI fragment. The gene has been located within a 2.2 kb HindIII-ClaI fragment and shown to span a 700 bp XbaI fragment within this fragment.
The ability of the FPV DNA fragments with flanking vaccinia sequences to operate in marker rescue, irrespective of the orientation with respect to the vaccinia promoter (P-F), suggests that the vaccinia virus RNA polymerase was able to recognize the FPV promoter sequences of the FPV TK gene. Conversely, vaccinia virus promoter sequences might be expected to operate in FPV, although perhaps at reduced efficiency. The apparent ability of the vaccinia virus RNA polymerase to recognize promoters of other poxviruses may be one of the mechanisms operating in the non-genetic reactivation of poxviruses from different genera. The identification of a FPV DNA fragment containing a functional TK gene will permit the characterization of the gene with respect to its nucleotide sequence, mRNA transcripts, promoter and TK enzyme product. Further, identification of the FPV TK will allow selective and non-selective protocols to be developed for the insertion of foreign DNA into FPV. Such recombinant viruses may offer great potential as avian vaccine vectors. Initially vaccinia virus promoters could be used to express these foreign genes; vaccinia virus promoters might be expected to operate in FPV. However, it will be desirable to identify FPV promoters in addition to the TK promoter since they might be expected to operate with greater efficiency.
The power of the TK selection protocol should allow this shotgun cloning approach to be used to identify and clone TK genes of other poxviruses, provided the poxvirus promoter operates sufficiently in vaccinia virus for functional TK enzyme to be expressed. Further, since the HSV TK gene is expressed when at 850 bp from the vaccinia promoter , this may permit the cloning of TK genes from DNA viruses other than poxviruses, e.g. herpesviruses.
In addition to the TK, vaccinia virus could be used to clone other genes of poxviruses, e.g. genes that complement vaccinia temperature-sensitive mutants and drug sensitivity mutants. Using immunological detection, it may be possible to identify and clone the genes of immunologically important antigens from other poxviruses, e.g. protective antigens. Similarly, this might be applied to other DNA viruses. Some level of expression of the influenza haemagglutinin has been achieved with large promoter-to-gene distances (greater than 4 kb; Panicali et al., 1983) . Already vaccinia virus has been used to identify vaccinia virus genes that determine the host range of certain deletion mutants (Gillard et al., 1985) . Here it has been used as a powerful selection and cloning vehicle to identify the FPV TK gene. As well as being used for vaccination purposes, vaccinia virus may be a useful eukaryotic cloning system for the identification of some DNA virus genes.
